Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

ΔNp63α helps control a protein that stops cancer cells from spreading.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Iron deficiency is not a significant cause of hair loss in women.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Prominin-1 expressing cells in the dermal papilla help regulate hair follicle size and communication but don't aid in skin repair.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Using finasteride with TIP extends time off period for prostate cancer patients.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Menopause affects hair and skin; more research needed for treatment.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Bariatric surgery affects skin health, causing both direct complications and changes in existing skin conditions, often related to nutritional deficiencies.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Dermoscopy has greatly improved the diagnosis of skin lesions and our understanding of their morphology and biology.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Meis1 is crucial for skin health and tumor development.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.